- Home
- AVDL vs WDI Comparison
AVDL vs WDI Comparison
Compare AVDL & WDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVDL
- WDI
- Stock Information
- Founded
- AVDL 2015
- WDI 2021
- Country
- AVDL Ireland
- WDI United States
- Employees
- AVDL N/A
- WDI N/A
- Industry
- AVDL Biotechnology: Pharmaceutical Preparations
- WDI Trusts Except Educational Religious and Charitable
- Sector
- AVDL Health Care
- WDI Finance
- Exchange
- AVDL Nasdaq
- WDI Nasdaq
- Market Cap
- AVDL 861.4M
- WDI 753.0M
- IPO Year
- AVDL 1996
- WDI N/A
- Fundamental
- Price
- AVDL $10.83
- WDI $14.97
- Analyst Decision
- AVDL Strong Buy
- WDI
- Analyst Count
- AVDL 7
- WDI 0
- Target Price
- AVDL $18.71
- WDI N/A
- AVG Volume (30 Days)
- AVDL 1.6M
- WDI 192.6K
- Earning Date
- AVDL 08-07-2025
- WDI 01-01-0001
- Dividend Yield
- AVDL N/A
- WDI 11.80%
- EPS Growth
- AVDL N/A
- WDI N/A
- EPS
- AVDL N/A
- WDI 1.12
- Revenue
- AVDL $194,450,000.00
- WDI N/A
- Revenue This Year
- AVDL $56.86
- WDI N/A
- Revenue Next Year
- AVDL $30.45
- WDI N/A
- P/E Ratio
- AVDL N/A
- WDI $12.82
- Revenue Growth
- AVDL 252.64
- WDI N/A
- 52 Week Low
- AVDL $6.38
- WDI $12.16
- 52 Week High
- AVDL $17.30
- WDI $14.69
- Technical
- Relative Strength Index (RSI)
- AVDL 72.02
- WDI 59.18
- Support Level
- AVDL $8.74
- WDI $14.80
- Resistance Level
- AVDL $9.56
- WDI $14.95
- Average True Range (ATR)
- AVDL 0.41
- WDI 0.09
- MACD
- AVDL 0.18
- WDI -0.00
- Stochastic Oscillator
- AVDL 89.88
- WDI 100.00
About AVDL Avadel Pharmaceuticals plc
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.
About WDI Western Asset Diversified Income Fund of Beneficial Interest
Western Asset Diversified Income Fund is a newly-organized, diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income.